ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,158.00
1.76%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36765
-0.34%
Bitcoin
58,999.79
1.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. CSL Limited (CSL)

  7. CSL Limited (CSL) News

CSL

CSL (CSL)

CSL Limited
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:CSL
DateTimeSourceHeadlineSymbolCompany
05/02/202311:44AMDow Jones NewsTravere Therapeutics Shares Touch 52-Week Low on FSGS Study DataASX:CSLCSL Limited
11/02/202210:34AMDow Jones NewsArcturus Therapeutics Shares Rise 31% After Vaccine CollaborationASX:CSLCSL Limited
11/01/20226:27PMDow Jones NewsArcturus Up 26% After Hours on CSL Seqirus Vaccine CollaborationASX:CSLCSL Limited
12/14/20212:54AMDow Jones NewsVifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 BillionASX:CSLCSL Limited
12/14/20211:00AMDow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd UpdateASX:CSLCSL Limited
12/14/202112:49AMDow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- UpdateASX:CSLCSL Limited
12/14/202112:24AMDow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor PharmaASX:CSLCSL Limited
12/12/20216:49PMDow Jones NewsCSL in Talks With Vifor Pharma Over Potential TransactionASX:CSLCSL Limited
12/10/20206:57PMDow Jones NewsCovid-19 Vaccine Candidate Scrapped After False Positives on HIV TestsASX:CSLCSL Limited
09/06/20206:06PMDow Jones NewsCSL Signs 2 Initial Agreements for Coronavirus Vaccine SupplyASX:CSLCSL Limited
08/19/20204:46AMDow Jones NewsCoronavirus Pandemic Slashes Donations of Lifesaving PlasmaASX:CSLCSL Limited
12/09/20198:12AMDow Jones NewsCSL Bering Gets FDA Orphan Designation for HizentraASX:CSLCSL Limited
05/14/20198:20AMDow Jones NewsHaemonetics Cuts Guidance on CSL Plasma DealASX:CSLCSL Limited
10/23/20187:58AMDow Jones NewsSeqirus Gets FDA Approval for Afluria Quadrivalent in Young ChildrenASX:CSLCSL Limited
12/01/20165:05AMNewspaperShould you buy Australian Foundation Investment Co Ltd?ASX:CSLCSL Limited
07/27/20162:32AMDow Jones NewsAustralia Stocks Close Near Flat After Mixed Inflation DataASX:CSLCSL Limited
07/26/20162:14AMDow Jones NewsAustralia Stocks End up Slightly as Key Inflation Data LoomsASX:CSLCSL Limited
10/15/20156:37PMDow Jones NewsCSL Catches Cold from Flu Vaccines Deal with Novartis -- Market TalkASX:CSLCSL Limited
08/16/20159:19PMDow Jones NewsIs A$100 a Share Cursed? -- Market TalkASX:CSLCSL Limited
08/04/20153:18AMDow Jones NewsAustralian Shares End Higher, Helped by Earnings and Sales DataASX:CSLCSL Limited
07/28/20153:28AMDow Jones NewsAustralia Shares End Slightly Down; Energy Stocks RiseASX:CSLCSL Limited
04/22/20156:20PMDow Jones NewsCSL Says CFO Naylor to Lead Influenza-Vaccine BusinessASX:CSLCSL Limited
03/16/201510:01PMThe Motley FoolWhat do rising U.S. interest rates mean for Australian companies? ASX:CSLCSL Limited
02/10/201511:54PMDow Jones NewsCSL Shaves Guidance as Competition Heats Up-- UpdateASX:CSLCSL Limited
12/03/20146:18AMDow Jones NewsDrooping Commodities Hurt Down Under -- Barron's AsiaASX:CSLCSL Limited
10/26/20149:31PMDow Jones NewsCSL to Buy Novartis Influenza-Vaccine UnitASX:CSLCSL Limited
10/26/20145:49PMDow Jones NewsCSL to Buy Novartis Influenza-Vaccine Unit for $275 MillionASX:CSLCSL Limited
01/24/20141:22AMDow Jones NewsAustralia Shares End Lower on China Growth Concerns, DataASX:CSLCSL Limited
01/13/20146:20AMDow Jones NewsU.S. Stock Futures Are LowerASX:CSLCSL Limited
01/12/20146:44PMDow Jones NewsS&P/ASX 200 Down 0.2% in Quiet TradeASX:CSLCSL Limited
 Showing the most relevant articles for your search:ASX:CSL

Your Recent History

NASDAQ
JAGX
Jaguar Health
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
ACRL
Atacama Resources (PK)
NASDAQ
VERB
Verb Technology
USOTC
TSOI
Therapeutic Solutions (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
SPZI
Spooz (PK)
USOTC
ILST
International Star (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
MULN
Mullen Automotive
USOTC
BABL
Buildablock (PK)
USOTC
FBEC
FBEC Worldwide (PK)
NASDAQ
AMRN
Amarin
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RXMD
Progressive Care (QB)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved